We thank Perlemuter and Yomtov (1) for their comments in this issue of Diabetes Care regarding our article (2). It seems that their previous study (3) and our study show similar results. They did not provide the ages of their participants, but “nine men and one woman” are mentioned, and our suspicion is that these subjects were a bit older than those in our population. It was also not stated if the subjects had type 1 or type 2 diabetes, though the latter seems likely. As our study dealt specifically with people 15–20 years of age with type 1 diabetes, it is likely that the two experiences are complementary. The main difference between our studies is in the response method, e-mail versus telephone. There are advantages to both methods. E-mail saves time when compared with the necessary repeat phone calls when people are not at home. The telephone allows person-to-person contact in which questions and answers can be used to reach a conclusion. It is also not as limited in dealing with the drawback mentioned by Perlemuter and Yomtov, that of dealing with emergencies. Currently, our clinic staff very effectively handles 20–30 calls per day related to ketones (4) or hypoglycemia. Subjects currently using e-mail switch to telephone calls for emergencies. A major goal of our study was to determine if e-mail communication could reduce the need for clinic visits for some subjects, and this was shown to be the case. We certainly agree that the electronic transmission of medical data is feasible and beneficial.

1.
Perlemuter L, Yomtov B: Modem transmission of glucose values reduces the costs and need for clinic visits: response to Chase et al. (Letter).
Diabetes Care
26
:
2969
,
2003
.
2.
Chase HP, Roberts MD, Pearson JA, Oderberg AD, Wightman C, Garg SK: Modem transmission of glucose values reduces the costs and need for clinic visits.
Diabetes Care
26
:
1475
–1479,
2003
3.
Perlemuter L, Yomtov B: Feasibility and usefulness of dedicated software and e-mail for self-monitoring blood glucose in treating diabetes (Letter).
Diabet Med
19
:
701
–702,
2002
4.
Travaglini MT, Garg SK, Chase HP: Use of insulin lispro in the outpatient management of ketonuria.
Arch Pediatr Adolesc Med
152
:
672
–675,
1998